Episode

#22, S2 The Year's Most Important Thoracic Oncology Papers, Part 1

Podcast
Thinking Thoracic
Published
Jun 18, 2026
Duration seconds
2850
Processing state
not_requested
Canonical source
https://thinkingthoracic.podbean.com/e/22-s2-the-years-most-important-thoracic-oncology-papers-part-1/
Audio
https://mcdn.podbean.com/mf/web/ax4q37dtsus4xmem/TT-e24-Martin-part1.mp3
JSON
/v1/public/podcasts/thinking-thoracic-7116337/episodes/22-s2-the-year-s-most-important-thoracic-oncology-papers-part-1
Markdown
/podcast/thinking-thoracic-7116337/22-s2-the-year-s-most-important-thoracic-oncology-papers-part-1.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/thinking-thoracic-7116337/episodes/22-s2-the-year-s-most-important-thoracic-oncology-papers-part-1/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/thinking-thoracic-7116337/22-s2-the-year-s-most-important-thoracic-oncology-papers-part-1.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In Part 1 of this special Thinking Thoracic episode, Dr. Jeff Yang welcomes Dr. Linda Martin for a discussion of groundbreaking research spanning immunotherapy, lung cancer epidemiology, and screening. Together, they explore emerging organ-preserving strategies for mismatch repair-deficient cancers, the growing population of patients with lung cancer who have never smoked, and new data highlighting opportunities to improve screening eligibility and uptake. Hear expert analysis of the studies shaping the future of thoracic oncology and what these findings mean for surgeons and patients alike.